Research Antibodies Market Report: Trends, Forecast and Competitive Analysis to 2030

Research Antibodies Trends and Forecast

The future of the global research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets. The global research antibodies market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.

A more than 150-page report is developed to help in your business decisions.

Research Antibodies by Segment

The study includes a forecast for the global research antibodies by product, type, technology, end use, and region.

Research Antibodies Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Primary Antibodies
• Secondary Antibodies

Research Antibodies Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Monoclonal Antibodies
• Polyclonal Antibodies

Research Antibodies Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Immunohistochemistry
• Munofluorescence
• Western Blotting
• Flow Cytometry
• Immunoprecipitation
• Elisa
• Others

Research Antibodies Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Academic & Research Institutes
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies

Research Antibodies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Research Antibodies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies research antibodies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the research antibodies companies profiled in this report include-

• Abcam
• Merck
• Thermo Fisher Scientific
• Cell Signalling Technology
• Santa Cruz Biotechnology
• Perkinelmer
• Becton and Dickinson

Research Antibodies Market Insights

Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..

Within this market, immunohistochemistry will remain the largest segment due to its substantial applications in the detection of enzymes, antigens, tumor suppressor genes, and tumor cell proliferation for cell-based research.

North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.

Features of the Global Research Antibodies Market

Market Size Estimates: Research antibodies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Research antibodies market size by various segments, such as by product, type, technology, end use, and region in terms of value ($B).

Regional Analysis: Research antibodies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, technologies, end uses, and regions for the research antibodies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the research antibodies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the research antibodies market size?

Answer: The global research antibodies market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for research antibodies market?

Answer: The global research antibodies market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the research antibodies market?

Answer: The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.

Q4. What are the major segments for research antibodies market?

Answer: The future of the research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets.

Q5. Who are the key research antibodies market companies?

Answer: Some of the key research antibodies companies are as follows:

• Abcam
• Merck
• Thermo Fisher Scientific
• Cell Signalling Technology
• Santa Cruz Biotechnology
• Perkinelmer
• Becton and Dickinson

Q6. Which research antibodies market segment will be the largest in future?

Answer: Lucintel forecasts that monoclonal antibodies will remain the larger segment over the forecast period due to monoclonal antibodies uses in the discovery and development of new treatments for various cancer types and rise in the number of initiatives in cancer research that call for highly selective antibodies..

Q7. In research antibodies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the growing focus on stem cells, biomedicine, and cancer research and rising investment in the development of structure-based drug designs in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the research antibodies market by product (primary antibodies and secondary antibodies), type (monoclonal antibodies and polyclonal antibodies), technology (immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, elisa, and others), end use (academic & research institutes, contract research organizations, and pharmaceutical & biotechnology companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?